|
|
|
|
LEADER |
01000naa a22002652 4500 |
001 |
NLM162942419 |
003 |
DE-627 |
005 |
20231223095305.0 |
007 |
tu |
008 |
231223s2006 xx ||||| 00| ||eng c |
028 |
5 |
2 |
|a pubmed24n0543.xml
|
035 |
|
|
|a (DE-627)NLM162942419
|
035 |
|
|
|a (NLM)16713741
|
040 |
|
|
|a DE-627
|b ger
|c DE-627
|e rakwb
|
041 |
|
|
|a eng
|
100 |
1 |
|
|a Xu, Zhiwei
|e verfasserin
|4 aut
|
245 |
1 |
0 |
|a STAT4 deficiency reduces autoantibody production and glomerulonephritis in a mouse model of lupus
|
264 |
|
1 |
|c 2006
|
336 |
|
|
|a Text
|b txt
|2 rdacontent
|
337 |
|
|
|a ohne Hilfsmittel zu benutzen
|b n
|2 rdamedia
|
338 |
|
|
|a Band
|b nc
|2 rdacarrier
|
500 |
|
|
|a Date Completed 07.09.2006
|
500 |
|
|
|a Date Revised 14.11.2007
|
500 |
|
|
|a published: Print-Electronic
|
500 |
|
|
|a Citation Status MEDLINE
|
520 |
|
|
|a To determine the respective role of the IL-12 and IL-4 pathways in the pathogenesis of systemic lupus erythematosus, we bred the Stat4 and Stat6 null alleles onto the lupus-prone mouse B6.TC, which is a congenic derivative of NZM2410. This model is characterized by abnormal splenocyte expansion, distribution and architecture, T cell activation, peripheral B cell development, production of anti-nuclear antibodies, and proliferative glomerulonephritis. STAT4 deficiency normalized the expression of each of these disease markers toward or to C57BL/6 levels. In contrast, STAT6 deficiency impacted splenocyte expansion and architecture, T cell activation, and anti-nuclear autoantibody production, but without any significant effect on B cell development or renal pathology. These results show that the IL-12/STAT4 pathway is involved in multiple disease-associated phenotypes in the B6.TC mouse. In contrast, the IL-4/STAT6 pathway regulates only a subset of disease markers that did not affect renal pathology
|
650 |
|
4 |
|a Journal Article
|
650 |
|
4 |
|a Research Support, N.I.H., Extramural
|
650 |
|
7 |
|a Autoantibodies
|2 NLM
|
650 |
|
7 |
|a Cytokines
|2 NLM
|
650 |
|
7 |
|a STAT4 Transcription Factor
|2 NLM
|
650 |
|
7 |
|a STAT6 Transcription Factor
|2 NLM
|
700 |
1 |
|
|a Duan, Biyan
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Croker, Byron P
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Morel, Laurence
|e verfasserin
|4 aut
|
773 |
0 |
8 |
|i Enthalten in
|t Clinical immunology (Orlando, Fla.)
|d 1999
|g 120(2006), 2 vom: 14. Aug., Seite 189-98
|w (DE-627)NLM098196855
|x 1521-7035
|7 nnns
|
773 |
1 |
8 |
|g volume:120
|g year:2006
|g number:2
|g day:14
|g month:08
|g pages:189-98
|
912 |
|
|
|a GBV_USEFLAG_A
|
912 |
|
|
|a SYSFLAG_A
|
912 |
|
|
|a GBV_NLM
|
912 |
|
|
|a GBV_ILN_11
|
912 |
|
|
|a GBV_ILN_24
|
912 |
|
|
|a GBV_ILN_350
|
951 |
|
|
|a AR
|
952 |
|
|
|d 120
|j 2006
|e 2
|b 14
|c 08
|h 189-98
|